zhang xiaofeng – Trademark Portfolio
Entity Type: 01
zhang xiaofeng owns a portfolio of 83 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as SUGT, BEMAL, ERIVC, KPPIT, and NAVAC. Of these, 73 are registered and 2 are pending. The portfolio spans 16 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 8 (Hand Tools). Headquartered in yuzhoushi.
xinhualu 24 hao
yuzhoushi 461670 , CN
Showing of trademarks Trademarks
Trademark Classifications
zhang xiaofeng's trademark portfolio spans 16 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does zhang xiaofeng have?
zhang xiaofeng has 83 U.S. trademarks filed with the USPTO. Of these, 73 registered, 2 pending, 2 abandoned, 6 cancelled.
What trademark classes does zhang xiaofeng file in?
zhang xiaofeng files trademarks across 16 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 8 (Hand Tools), Class 16 (Paper Goods), Class 28 (Toys & Sporting Goods), Class 25 (Clothing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are zhang xiaofeng's most well-known trademarks?
zhang xiaofeng's registered trademark portfolio includes well-known marks such as SUGT, BEMAL, ERIVC, KPPIT, and NAVAC. These are among 73 currently registered trademarks in the portfolio.
What is zhang xiaofeng's trademark registration success rate?
zhang xiaofeng has a 90% trademark registration rate, with 73 out of 81 resolved applications resulting in successful registration. Currently, 2 applications are pending review.